Two-sample Mendelian randomization studies revealed a causal relationship between insulin use and osteoporosis: An observational study
- PMID: 38941431
- PMCID: PMC11466163
- DOI: 10.1097/MD.0000000000038535
Two-sample Mendelian randomization studies revealed a causal relationship between insulin use and osteoporosis: An observational study
Abstract
Objective: To investigate causal associations between diabetes, insulin treatment and osteoporosis using LDSC analysis with a 2-way Mendelian randomization study.
Methods: LDSC analysis was used to estimate the likelihood-scale heritability of the genome-wide association study used with genetic correlation between the 2 genome-wide association study used. Then a 2-sample Mendelian randomization study was performed using 3 methods including inverse variance weighted, MR Egger, and weighted median.
Results: The genetic correlation between diabetes, insulin treatment (h2_Z = 3.70, P = 2.16e-4), osteoporosis (h2_Z = 4.93, h2_p = 8.13e-7) and genes was significant. There was a significant genetic correlation (rg = 0.122, P = 0.0211). There was a causal association between diabetes, insulin treatment and osteoporosis [P = 0.003754, OR (95%CI) = 0.998876 (0.998116-0.999636)], while no causal association existed between osteoporosis and insulin use (P = 0.998116-0.999636) causal association existed (P = 0.333244).
Conclusion: There was a strong genetic correlation between diabetes, insulin treatment and osteoporosis, a causal association between diabetes, insulin treatment and osteoporosis, and no causal association between osteoporosis and diabetes, insulin treatment.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures
Similar articles
-
Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.Osteoporos Int. 2023 Jun;34(6):1111-1117. doi: 10.1007/s00198-023-06734-6. Epub 2023 Apr 3. Osteoporos Int. 2023. PMID: 37012460
-
Two-sample Mendelian randomization analysis evaluates causal associations between inflammatory bowel disease and osteoporosis.Front Public Health. 2023 May 26;11:1151837. doi: 10.3389/fpubh.2023.1151837. eCollection 2023. Front Public Health. 2023. PMID: 37304119 Free PMC article.
-
Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study.Front Endocrinol (Lausanne). 2023 Aug 9;14:1215790. doi: 10.3389/fendo.2023.1215790. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37621646 Free PMC article.
-
A Causal Relationship Between Type 1 Diabetes and Risk of Osteoporosis: A Univariable and Multivariable Mendelian Randomization Study.J Diabetes Res. 2024 May 8;2024:1610688. doi: 10.1155/2024/1610688. eCollection 2024. J Diabetes Res. 2024. PMID: 38751603 Free PMC article.
-
Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2025 Jan 16;15:1486188. doi: 10.3389/fendo.2024.1486188. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39886030 Free PMC article.
References
-
- Schwartz AV. Diabetes, bone and glucose-lowering agents: clinical outcomes. Diabetologia. 2017;60:1170–9. - PubMed
-
- Black DM, Delmas PD, Eastell R, et al. .; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809–22. - PubMed
-
- Cummings SR, San MJ, McClung MR, et al. . Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–65. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical